2021 annual financial data
CytoMed Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,039.71%.
Operating income was -1,156,262 SGD and net income was -2,073,680 SGD.
Operating cash flow was -1,716,990 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 84,178 SGD
- Operating income
- -1,156,262 SGD
- Net income
- -2,073,680 SGD
- Operating cash flow
- -1,716,990 SGD